Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

NCT01625494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Irbesartan/Amlodipine (150/5mg)
DRUG: Irbesartan/Amlodipine (150/10mg)
DRUG: Irbesartan/Amlodipine (300/5mg)
DRUG: Irbesartan/Amlodipine (300/10mg)

Sponsor

Sanofi